SpringWorks Therapeutics, Inc.
- CIK: 0001773427
- EIN: 00-0000000
- Business address: 100 WASHINGTON BOULEVARD, STAMFORD, Connecticut, 06902
Information
Mailing address
100 WASHINGTON BOULEVARD, STAMFORD, Delaware, 06902Phone
203-883-9490State location
ConnecticutState of incorporation
DelawareFiscal year end
December 31SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)Filings
N/A
About SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. (CIK: 0001773427) is an American company incorporated in the state of Connecticut. Head office is located at 100 WASHINGTON BOULEVARD, STAMFORD, Connecticut, 06902. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SpringWorks Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Lin Tai-An | 0001991985 | Sep-11-2023 | officer: Chief Scientific Officer |
| Cassidy James | 0001949023 | Oct-06-2022 | officer: Chief Medical Officer |
| ALBAN CARLOS | 0001474632 | Jul-14-2022 | director |
| Burgess Michael F. | 0001801745 | May-10-2021 | officer: Head of Research & Development |
| Ashar Bhavesh | 0001849740 | Mar-22-2021 | officer: Chief Commercial Officer |
| ORBIMED ADVISORS LLC | 0001055951 | Mar-01-2021 | 10 percent owner |
| OrbiMed Capital GP VI LLC | 0001682115 | Mar-01-2021 | 10 percent owner |
| Pichl Daniel | 0001819465 | Aug-03-2020 | officer: Chief People Officer |
| LYNCH DANIEL | 0001177082 | May-20-2020 | director, 10 percent owner |
| Fuhrman Alan | 0001303521 | May-20-2020 | director |
| Lewis-Hall Freda C | 0001437909 | May-20-2020 | director, 10 percent owner |
| Hambleton Julie | 0001578771 | May-20-2020 | director |
| SQUINTO STEPHEN P | 0001231954 | Mar-12-2020 | director, 10 percent owner |
| Francis Perier I Jr | 0001304404 | Mar-02-2020 | officer: Chief Financial Officer |
| Islam Saqib | 0001575408 | Mar-02-2020 | director, officer: Chief Executive Officer |
| Edris Badreddin | 0001786966 | Mar-02-2020 | officer: Chief Business Officer |
| Renstrup Jens | 0001786967 | Mar-02-2020 | officer: Chief Medical Officer |
| Smith L. Mary | 0001787013 | Mar-02-2020 | officer: See Remarks |
| Weinstein Herschel S | 0001349008 | Jan-27-2020 | officer: General Counsel & Secretary |
| Nofi Michael | 0001705477 | Nov-11-2019 | officer: Chief Accounting Officer |
| PFIZER INC | 0000078003 | Sep-12-2019 | 10 percent owner |
| PATRICK DEVAL L | 0001053466 | Sep-12-2019 | director |
| GORDON CARL L | 0001282930 | Sep-12-2019 | director, 10 percent owner |
| Koppel Adam | 0001578965 | Sep-12-2019 | 10 percent owner |
| Schwartz Jeffrey Lawrence | 0001702957 | Sep-12-2019 | director, 10 percent owner |
| Bain Capital Life Sciences Investors, LLC | 0001703031 | Sep-12-2019 | 10 percent owner |
| Pfizer Ventures (US) LLC | 0001776087 | Sep-12-2019 | 10 percent owner |
| BC SW, LP | 0001786351 | Sep-12-2019 | 10 percent owner |
| Greco Michael V. | 0001786766 | Sep-12-2019 | officer: General Counsel & Secretary |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SpringWorks Therapeutics, Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-096872 ( Act) Size: 0 KB |
Sep-04-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-096869 ( Act) Size: 0 KB |
Sep-04-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000786 (33 Act) Size: 0 KB |
Sep-03-2024 | 241274128 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000785 (33 Act) Size: 0 KB |
Sep-03-2024 | 241274078 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-096360 ( Act) Size: 0 KB |
Sep-03-2024 | |
| 8-K | Document | Current report filing Acc-no: 0001773427-24-000027 (34 Act) Size: KB |
Aug-07-2024 | 241181324 |
| 10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001773427-24-000025 (34 Act) Size: KB |
Aug-07-2024 | 241181319 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-083966 ( Act) Size: 0 KB |
Jul-30-2024 | |
| 3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001104659-24-083964 ( Act) Size: 0 KB |
Jul-30-2024 | |
| 8-K | Document | Current report filing Acc-no: 0001104659-24-083955 (34 Act) Size: KB |
Jul-30-2024 | 241157253 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-077347 ( Act) Size: 0 KB |
Jul-02-2024 | |
| 8-K | Document | Current report filing Acc-no: 0001104659-24-069653 (34 Act) Size: KB |
Jun-07-2024 | 241029619 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-068675 ( Act) Size: 0 KB |
Jun-05-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-068674 ( Act) Size: 0 KB |
Jun-05-2024 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-068673 ( Act) Size: 0 KB |
Jun-05-2024 | |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000446 (33 Act) Size: 0 KB |
Jun-03-2024 | 241014428 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000444 (33 Act) Size: 0 KB |
Jun-03-2024 | 241014314 |
| 144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001968582-24-000443 (33 Act) Size: 0 KB |
Jun-03-2024 | 241014266 |
| 8-K | Document | Current report filing Acc-no: 0001104659-24-063076 (34 Act) Size: KB |
May-17-2024 | 24960787 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-062992 ( Act) Size: 0 KB |
May-17-2024 |
Recent 20 filings. View all SpringWorks Therapeutics, Inc. filings
Reviews
Pelisari
young lad who new his job ansered questions and new what was best for me.
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Catherine
Thanks I look forward to using the product to improve my skin tone
Frequently Asked Questions
Tags:
- SpringWorks Therapeutics, Inc. overview
- SpringWorks Therapeutics, Inc. job
- SpringWorks Therapeutics, Inc. stock
- SpringWorks Therapeutics, Inc. ownership
- SpringWorks Therapeutics, Inc. CEO
- SpringWorks Therapeutics, Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023
Lexeo Therapeutics, Inc.
Update: Nov 02, 2023
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 